-
Je něco špatně v tomto záznamu ?
Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta
M. Zhao, A. Nanbo, D. Becnel, Z. Qin, GF. Morris, L. Li, Z. Lin
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
P20 GM121288
NIGMS NIH HHS - United States
NLK
Free Medical Journals
od 1967 do Před 6 měsíci
Freely Accessible Science Journals
od 1967 do Před 6 měsíci
PubMed Central
od 1967 do Před 1 rokem
Europe PubMed Central
od 1967 do Před 6 měsíci
Open Access Digital Library
od 1967-02-01
Open Access Digital Library
od 1967-02-01
PubMed
32847852
DOI
10.1128/jvi.01298-20
Knihovny.cz E-zdroje
- MeSH
- buněčné linie MeSH
- infekce virem Epsteina-Barrové virologie MeSH
- lidé MeSH
- mutace MeSH
- promotorové oblasti (genetika) MeSH
- proteinové domény MeSH
- regulace exprese virových genů MeSH
- replikace viru MeSH
- trans-aktivátory genetika metabolismus MeSH
- ubikvitin metabolismus MeSH
- vazba proteinů MeSH
- virové proteiny genetika metabolismus MeSH
- virus Epsteinův-Barrové genetika fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
The Epstein-Barr virus (EBV) immediate early transactivator Zta plays a key role in regulating the transition from latency to the lytic replication stages of EBV infection. Regulation of Zta is known to be controlled through a number of transcriptional and posttranscriptional events. Here, we show that Zta is targeted for ubiquitin modification and that this can occur in EBV-negative and in EBV-infected cells. Genetic studies show critical roles for both an amino-terminal region of Zta and the basic DNA binding domain of Zta in regulating Zta ubiquitination. Pulse-chase experiments demonstrate that the bulk population of Zta is relatively stable but that at least a subset of ubiquitinated Zta molecules are targeted for degradation in the cell. Mutation of four out of a total of nine lysine residues in Zta largely abrogates its ubiquitination, indicating that these are primary ubiquitination target sites. A Zta mutant carrying mutations at these four lysine residues (lysine 12, lysine 188, lysine 207, and lysine 219) cannot induce latently infected cells to produce and/or release infectious virions. Nevertheless, this mutant can induce early gene expression, suggesting a possible defect at the level of viral replication or later in the lytic cascade. As far as we know, this is the first study that has investigated the targeting of Zta by ubiquitination or its role in Zta function.IMPORTANCE Epstein-Barr virus (EBV) is a ubiquitous human pathogen and associated with various human diseases. EBV undergoes latency and lytic replication stages in its life cycle. The transition into the lytic replication stage, at which virus is produced, is mainly regulated by the viral gene product, Zta. Therefore, the regulation of Zta function becomes a central issue regarding viral biology and pathogenesis. Known modifications of Zta include phosphorylation and sumoylation. Here, we report the role of ubiquitination in regulating Zta function. We found that Zta is subjected to ubiquitination in both EBV-infected and EBV-negative cells. The ubiquitin modification targets 4 lysine residues on Zta, leading to both mono- and polyubiquitination of Zta. Ubiquitination of Zta affects the protein's stability and likely contributes to the progression of viral lytic replication. The function and fate of Zta may be determined by the specific lysine residue being modified.
Department of Medicine Tulane University Health Sciences Center New Orleans Louisiana USA
Institute of Translational Research Ochsner Clinic Foundation New Orleans Louisiana USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011983
- 003
- CZ-PrNML
- 005
- 20210507103355.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1128/JVI.01298-20 $2 doi
- 035 __
- $a (PubMed)32847852
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zhao, Mengmeng $u Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA $u Tulane Cancer Center, New Orleans, Louisiana, USA
- 245 10
- $a Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta / $c M. Zhao, A. Nanbo, D. Becnel, Z. Qin, GF. Morris, L. Li, Z. Lin
- 520 9_
- $a The Epstein-Barr virus (EBV) immediate early transactivator Zta plays a key role in regulating the transition from latency to the lytic replication stages of EBV infection. Regulation of Zta is known to be controlled through a number of transcriptional and posttranscriptional events. Here, we show that Zta is targeted for ubiquitin modification and that this can occur in EBV-negative and in EBV-infected cells. Genetic studies show critical roles for both an amino-terminal region of Zta and the basic DNA binding domain of Zta in regulating Zta ubiquitination. Pulse-chase experiments demonstrate that the bulk population of Zta is relatively stable but that at least a subset of ubiquitinated Zta molecules are targeted for degradation in the cell. Mutation of four out of a total of nine lysine residues in Zta largely abrogates its ubiquitination, indicating that these are primary ubiquitination target sites. A Zta mutant carrying mutations at these four lysine residues (lysine 12, lysine 188, lysine 207, and lysine 219) cannot induce latently infected cells to produce and/or release infectious virions. Nevertheless, this mutant can induce early gene expression, suggesting a possible defect at the level of viral replication or later in the lytic cascade. As far as we know, this is the first study that has investigated the targeting of Zta by ubiquitination or its role in Zta function.IMPORTANCE Epstein-Barr virus (EBV) is a ubiquitous human pathogen and associated with various human diseases. EBV undergoes latency and lytic replication stages in its life cycle. The transition into the lytic replication stage, at which virus is produced, is mainly regulated by the viral gene product, Zta. Therefore, the regulation of Zta function becomes a central issue regarding viral biology and pathogenesis. Known modifications of Zta include phosphorylation and sumoylation. Here, we report the role of ubiquitination in regulating Zta function. We found that Zta is subjected to ubiquitination in both EBV-infected and EBV-negative cells. The ubiquitin modification targets 4 lysine residues on Zta, leading to both mono- and polyubiquitination of Zta. Ubiquitination of Zta affects the protein's stability and likely contributes to the progression of viral lytic replication. The function and fate of Zta may be determined by the specific lysine residue being modified.
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a infekce virem Epsteina-Barrové $x virologie $7 D020031
- 650 _2
- $a regulace exprese virových genů $7 D015967
- 650 _2
- $a virus Epsteinův-Barrové $x genetika $x fyziologie $7 D004854
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a proteinové domény $7 D000072417
- 650 _2
- $a trans-aktivátory $x genetika $x metabolismus $7 D015534
- 650 _2
- $a ubikvitin $x metabolismus $7 D025801
- 650 _2
- $a virové proteiny $x genetika $x metabolismus $7 D014764
- 650 _2
- $a replikace viru $7 D014779
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nanbo, Asuka $u National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki, Japan
- 700 1_
- $a Becnel, David $u Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
- 700 1_
- $a Qin, Zhiqiang $u Department of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
- 700 1_
- $a Morris, Gilbert F $u Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA $u Tulane Cancer Center, New Orleans, Louisiana, USA
- 700 1_
- $a Li, Li $u Institute of Translational Research, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
- 700 1_
- $a Lin, Zhen $u Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA zlin@tulane.edu $u Tulane Cancer Center, New Orleans, Louisiana, USA
- 773 0_
- $w MED00003048 $t Journal of virology $x 1098-5514 $g Roč. 94, č. 22 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32847852 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507103354 $b ABA008
- 999 __
- $a ok $b bmc $g 1650375 $s 1132362
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 94 $c 22 $e 20201027 $i 1098-5514 $m Journal of virology $n J Virol $x MED00003048
- GRA __
- $a P20 GM121288 $p NIGMS NIH HHS $2 United States
- LZP __
- $a Pubmed-20210420